Brief: IRLAB Therapeutics Q3 Net Operating Loss Narrows To Sek 29.4 Mln

IRLAB Therapeutics AB

30/10/2024 06:10

Oct 30 (Reuters) - IRLAB Therapeutics AB  IRLABa.ST :
    * Q3 NET SALES SEK 9.0 MILLION
    * Q3 NET OPERATING LOSS SEK 29.4 MILLION VERSUS LOSS SEK
40.7
MILLION YEAR AGO

Source text:  ID:nMFN5qYf5R 
Further company coverage:  IRLABa.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com;  +48 58 769 66 00;))